Home > Centrum prasowe > 10th Anniversary International Conference of Contemporary Oncology

10th Anniversary International Conference of Contemporary Oncology

10th Anniversary International Conference of Contemporary Oncology poznan 2017

W dniach 21–23 marca 2018 w Poznaniu odbędzie się 10th Anniversary International Conference of Contemporary Oncology. Organizatorem międzynarodowej konferencji dotyczącej onkologii spersonalizowanej jest wydawnictwo Termedia. W prestiżowym wydarzeniu wezmą udział światowej rangi naukowcy i eksperci w dziedzinie onkologii, a także wybitni onkolodzy i polscy badacze raka.

Dziesiąta edycja konferencji organizowana jest we współpracy z Wielkopolskim Centrum Onkologii, Międzynarodowym Instytutem Onkologii Molekularnej oraz Uniwersytetem Medycznym w Poznaniu. Spotkanie poświęcone będzie ekscytującej dziedzinie, jaką jest spersonalizowana onkologia. Eksperci przedstawią najnowsze doniesienia związane z immunoterapią nowotworów.

Wśród zaproszonych wykładowców znaleźli się: Tadeusz Burzykowski (Belgium, Poland), Magdalena Chechlińska (Poland), Salem Chouaib (France), Grzegorz Dworacki (Poland), Lidia Gil (Poland), J. Hybaeck (Germany), Paweł Kaliński (USA), Bożena Kamińska-Kaczmarek (Poland), Claudine Kieda (France, Poland), Iwona Ługowska (Poland), Jacek Mackiewicz (Poland), Waldemar Priebe (USA), Rodryg Ramlau (Poland), Christian Regenbrecht (Niemcy), Piotr Rutkowski (Poland), Pravin Seghal (USA), Cezary Szczylik (Poland), Victor Umansky (Germany), Therese Whiteside (USA).
 
10th International Conference of Contemporary Oncology
Termin: 21-23 marca 2018
Miejsce: IBB Andersia Hotel, Plac Andersa 3, Poznań, Poland
Rejestracja: www.termedia.pl
 

PROGRAM I ZAKRES TEMATYCZNY KONFERENCJI

INTERNATIONAL CONFERENCE OF CONTEMPORARY ONCOLOGY 2018

21 MARCA – DZIEŃ 1

12:00–13:00 Snacks & Drinks

13:00–15:05 SESSION 1. INTERACTIONS BETWEEN HOST AND CANCER
Chairs: Magdalena CHECHLIŃSKA, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL, Jan LUBIŃSKI, Pomeranian Medical University, Szczecin, PL

13:00–13:25 Gene – environment interactions and cancer risk
Jan LUBIŃSKI, Pomeranian Medical University, Szczecin, PL

13:25–13:50 TCGA Legacy: Multi-Omics Studies in Cancer
Maciej WIZNEROWICZ, Poznan University of Medical Sciences Medical, Poznan, PL

13:50–14:15 Molecular changes in cancer-adjacent histologically normal epithelia
Magdalena CHECHLINSKA, Mariusz KULIŃCZAK, Maria SROMEK, Grzegorz PANEK, Klara ZAKRZEWSKA, Renata ŁATOCKA, Jan Konrad SIWICKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL

14:15–14:40 The role of the CRNDE oncogene in cancer development and screening
Łukasz SZAFRON, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL

14:40–15:05 The role of arginase-1 in antitumor immune response
Dominika NOWIS, Warsaw Medical University, Warsaw, PL

15:05–15:25 Coffee Break

15:25–17:50 SESSION 2. BIOMARKERS
Chairs: Theresa WHITESIDE, University of Pittsburgh Cancer Institute, PA, USA, Tomasz BURZYKOWSKI, University of Hasselt, Belgium

15:25–15:50 Potentials and pitfalls of biomarker-based adaptive-randomization in cancer trials
Tomasz BURZYKOWSKI, University of Hasselt, Belgium

15:50–16:15 Multi-parametric-monitoring predictive models of potentials and pitfalls of biomarker-based adaptive-randomization in cancer trials
Krzysztof SKŁADOWSKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, PL

16:15–16:40 Serum microRNAs as biomarkers of high-dose irradiation
Wojciech FOLTAN, Harvard Medical School, Boston, MA, USA

16:40–17:05 Tumor-derived exosomes as potential biomarkers of cancer progression and immune dysfunction in patients with melanoma
Theresa WHITESIDE, University of Pittsburgh Cancer Institute, PA, USA

17:05–17:30 Serum metabolomics – new approach to support early detection of lung cancer
Piotr WIDŁAK, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, PL

17:30–17:40 Presentation selected from abstracts
TBA

17:40–17:50 Presentation selected from abstracts
TBA

17:50–18:50 POSTER SESSION

18:50–19:50 OPENING CEREMONY AND WELCOME ADDRESS
Keynote lecture: T cell Therapy of Cancer: Green Eggs and Ham Cassian YEE, MD Anderson Cancer Center, Houston, TX, USA

20:00 DINNER for all registered participants

22 MARCA – DZIEŃ 2

9:00–11:25 SESSION 3. TUMOR MICROENVIRONMENT AND ITS TARGETING
Chairs: Salem CHOUAIB, Institute Goustave Roussy, Paris, FR, Martyna ELAS, Cracow, PL

9:00–9:25 Redox, oximetric and vascular imaging provide insight into tumor microenvironment
Martyna ELAS, Cracow, PL

9:25–9:50 Overcoming immunosuppression in tumor microenvironment
Viktor UMANSKY, DKFZ Heidelberg, DE

9:50–10:15 Tumor and its hypoxic microenvironment, what should be the target?
Claudine KIEDA, CNRS, Orléans, FR, Military Institute of Medicine, Warsaw, PL

10:15–10:40 Repolarizing tumor infiltrating immune cells to enhance antitumor therapy
Bożena KAMIŃSKA-KACZMAREK, Nencki Institute of Experimental Biology, Warsaw, PL

10:40–11:05 Functionalized bioengineered spider silk spheres for siRNA delivery to the tumor microenvironment in cancer therapy
Hanna DAMS-KOZŁOWSKA Poznan Medical University, Poznan, PL

11:05–11:15 Presentation selected from abstracts

11:15–11:25 Presentation selected from abstracts

11:25–11:50 Coffee break

11:50–13:55 SESSION 4. CANCER IMMUNOTHERAPY – NEW APPROACHES
Chairs: Paweł KALINSKI, Roswelt Park Memorial Institute, Buffalo, NY, USA

11:50–12:15 Combinatorial Adjuvants and Dendritic Cell Therapies Sensitize Converting “Cold” Tumors to Checkpoint Blockade
Paweł KALINSKI, Roswelt Park Memorial Institute, Buffalo, NY, USA

12:15–12:40 Chimeric antigen receptor-based therapies against solid tumors – work in progress
Radosław ZAGOŻDŻON, Warsaw Medical University, Warsaw, PL

12:40–13:05 TBA
Andrzej MACKIEWICZ, Poznan University of Medical Sciences Medical, Poznan, PL

13:05–13:30 TBA

13:30–13:55 TBA

13:55–14:55 Lunch

14:55–16:45 SESSION 5. TARGETED CANCE THERAPIES
Chairs: Piotr RUTKOWSKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL

14:55–15:20 How to optimize targeted therapy in gastrointestinal stromal tumors
Piotr RUTKOWSKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL

15:20–15:55 Advanced Renal Cell Carcinoma – novel targets, new drugs
Cezary SZCZYLIK, Warsaw Medical University, Warsaw, PL

15:55–16:20 Anticoagulants in cancer patients: beyond the antithrombotic effect
Marek WOJTUKIEWICZ, Bialystok Medical University, Bialystok, PL

16:20–16:45 Is personalized treatment of prostate cancer based on biomarkers possible?
Piotr RADZISZEWSKI, Warsaw Medical University, Warsaw, PL

16:45–17:15 Coffee break

17:15–18:25 SESSION 6. CANCER CELL BIOLOGY
Chairs: Pravin SEGHAL, New York Medical College, NY, USA

17:15–17:40 The MxA reticulum is a novel cytoplasmic organelle in cancer cells distinct from the standard reticulon-4-based endoplasmic reticulum (ER)
Pravin SEGHAL, New York Medical College, NY, USA

17:40–18:05 Significance and role of pattern recognition receptors in malignancy
Jan ŻEROMSKI, Poznan University of Medical Sciences, Poznan, PL

18:05–18:15 Presentation selected from abstracts

18:15–18:25 Presentation selected from abstracts

20:00 DINNER (TICKETED)

23 MARCA – DZIEŃ 3

9:00–11:35 CLINICAL SESSION 7: HAEMATOLOGICAL MALIGNANCES AS CANCER MODELS
Chairs: Lidia GIL, Poznan University of Medical Sciences, Poznan, PL, Waldemar PRIEBE, MD Anderson Cancer Center, Houston, TX, USA

9:00–9:25 Therapy of myelodysplastic syndrome based on molecular profiling
Lidia GIL, Poznan University of Medical Sciences, Poznan, PL

9:25–9:55 Innovative therapies for lymphoma
Iwona HUS, Lublin Medical University, Lublin, PL

9:55–10:25 TBA
Waldemar PRIEBE, MD Anderson Cancer Center, Houston, TX, USA

10:25–10:50 TBA

10:50–11:15 TBA

11:15–11:35 TBA

11:35–12:00 Coffee break

12:00–14:15 CLINICAL SESSION 8. CANCER IMMUNOTHERAPY AND COMBINATIONAL THERAPIES
Chairs: Jacek MACKIEWICZ, Poznan University of Medical Sciences, Poznan, PL

12:00–12:25 How to increase immunotherapy efficacy of renal cell carcinoma
Jacek MACKIEWICZ, Poznan University of Medical Sciences, Poznan, PL

12:25–12:50 Real-world treatment and outcomes of metastatic cutaneous melanoma patients treated with immunotherapy in Poland
Iwona ŁUGOWSKA, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL

12:50–13:15 Immunotherapy of non-small cell lung cancer patients – change of standard proceedings
Rodryg RAMLAU, Poznan University of Medical Sciences, Poznan, PL

13:15–13:40 Treatment strategy in patients with metastatic colorectal cancer – new perspectives
Rafał STEC, Military Institute of Medicine, Warsaw, PL

13:40–14:15 TBA

14:15–15:00 Lunch

15:00–17:20 SESSION 9. ORAL PRESENTATIONS FROM ABSTRACTS

 

10th Anniversary International Conference of Contemporary Oncology
5 głosów, średnia: 4.60 (wynik: 91%)
Powiązane materiały
Akademia Czerniaka 2018 – cykl konferencji na temat nowotworów skóry
XI Konferencja Polskiej Grupy Raka Płuca – BEST OF WCLC
konferencje dotyczące immunoterapii 2018
Międzynarodowe konferencje poświęcone immunoterapii
projekt stream, immunoonkologia
Warsztaty: Zastosowanie metod cytometrii przepływowej w immunoonkologii